Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $8.87 and traded as high as $14.00. Cipher Pharmaceuticals shares last traded at $13.66, with a volume of 9,934 shares.
Cipher Pharmaceuticals Stock Up 3.2 %
The company’s 50 day moving average is $8.87 and its 200 day moving average is $7.13.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
Featured Stories
- Five stocks we like better than Cipher Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- Overbought Stocks Explained: Should You Trade Them?
- Introduction to Fibonacci Retracement Levels
- Investing in Commodities: What Are They? How to Invest in Them
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
